{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:23:17Z","timestamp":1707524597756},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,17]]},"DOI":"10.7759\/cureus.23251","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T11:29:40Z","timestamp":1647516580000},"source":"Crossref","is-referenced-by-count":8,"title":["An Interesting Case of Fatal Myasthenic Crisis Probably Induced by the COVID-19 Vaccine"],"prefix":"10.7759","author":[{"given":"Khushboo J","family":"Sonigra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishan","family":"Sarna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinesh P","family":"Vaghela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Symon","family":"Guthua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus NE","year":"2016","unstructured":"Gilhus NE. Myasthenia gravis. N Engl J Med. 2016, 375:2570-81. 10.1056\/NEJMra1602678","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: past, present, and future","volume":"116","author":"Conti-Fine BM","year":"2006","unstructured":"Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis: past, present, and future. J Clin Invest. 2006, 116:2843-54. 10.1172\/JCI29894","journal-title":"J Clin Invest"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.145987","article-title":"Ocular myasthenia gravis: a review","volume":"62","author":"Nair AG","year":"2014","unstructured":"Nair AG, Patil-Chhablani P, Venkatramani DV, Gandhi RA. Ocular myasthenia gravis: a review. Indian J Ophthalmol. 2014, 62:985-91. 10.4103\/0301-4738.145987","journal-title":"Indian J Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/cells8070671","article-title":"Myasthenia gravis: pathogenic effects of autoantibodies on neuromuscular architecture","volume":"8","author":"Koneczny I","year":"2019","unstructured":"Koneczny I, Herbst R. Myasthenia gravis: pathogenic effects of autoantibodies on neuromuscular architecture. Cells. 2019, 8:671. 10.3390\/cells8070671","journal-title":"Cells"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus NE","year":"2019","unstructured":"Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren JJ. Myasthenia gravis. Nat Rev Dis Primers. 2019, 5:30. 10.1038\/s41572-019-0079-y","journal-title":"Nat Rev Dis Primers"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcn152","article-title":"Myasthenic crisis","volume":"102","author":"Chaudhuri A","year":"2009","unstructured":"Chaudhuri A, Behan PO. Myasthenic crisis. QJM. 2009, 102:97-107. 10.1093\/qjmed\/hcn152","journal-title":"QJM"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-829595","article-title":"Myasthenia gravis: management of myasthenic crisis and perioperative care","volume":"24","author":"Juel VC","year":"2004","unstructured":"Juel VC. Myasthenia gravis: management of myasthenic crisis and perioperative care. Semin Neurol. 2004, 24:75-81. 10.1055\/s-2004-829595","journal-title":"Semin Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000776","article-title":"COVID-19 and autoimmune diseases","volume":"33","author":"Liu Y","year":"2021","unstructured":"Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol. 2021, 33:155-62. 10.1097\/BOR.0000000000000776","journal-title":"Curr Opin Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2174\/1871528114666160105113046","article-title":"Vaccination and induction of autoimmune diseases","volume":"14","author":"Toussirot \u00c9","year":"2015","unstructured":"Toussirot \u00c9, Bereau M. Vaccination and induction of autoimmune diseases. Inflamm Allergy Drug Targets. 2015, 14:94-8. 10.2174\/1871528114666160105113046","journal-title":"Inflamm Allergy Drug Targets"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-06041-7","article-title":"New-onset giant cell arteritis following COVID-19 mRNA (BioNTech\/Pfizer) vaccine: a double-edged sword?","author":"Anzola AM","year":"2022","unstructured":"Anzola AM, Trives L, Mart\u00ednez-Barrio J, Pinilla B, \u00c1lvaro-Gracia JM, Molina-Collada J. New-onset giant cell arteritis following COVID-19 mRNA (BioNTech\/Pfizer) vaccine: a double-edged sword?. Clin Rheumatol. 2022, 10.1007\/s10067-021-06041-7","journal-title":"Clin Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15581","article-title":"A case of COVID-19 vaccine causing a myasthenia gravis crisis","volume":"13","author":"Tagliaferri AR","year":"2021","unstructured":"Tagliaferri AR, Narvaneni S, Azzam MH, Grist W. A case of COVID-19 vaccine causing a myasthenia gravis crisis. Cureus. 2021, 13:e15581. 10.7759\/cureus.15581","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9101112","article-title":"COVID-19 vaccination in patients with myasthenia gravis: a single-center case series","volume":"9","author":"Ruan Z","year":"2021","unstructured":"Ruan Z, Tang Y, Li C, Sun C, Zhu Y, Li Z, Chang T. COVID-19 vaccination in patients with myasthenia gravis: a single-center case series. Vaccines (Basel). 2021, 9:1112. 10.3390\/vaccines9101112","journal-title":"Vaccines (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168965","article-title":"Adaptive immunity and the risk of autoreactivity in COVID-19","volume":"22","author":"Moody R","year":"2021","unstructured":"Moody R, Wilson K, Flanagan KL, Jaworowski A, Plebanski M. Adaptive immunity and the risk of autoreactivity in COVID-19. Int J Mol Sci. 2021, 22:8965. 10.3390\/ijms22168965","journal-title":"Int J Mol Sci"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(03)14802-7","article-title":"Vaccination and autoimmune disease: what is the evidence?","volume":"362","author":"Wraith DC","year":"2003","unstructured":"Wraith DC, Goldman M, Lambert PH. Vaccination and autoimmune disease: what is the evidence?. Lancet. 2003, 362:1659-66.","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01630-0","article-title":"Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection","volume":"28","author":"Patone M","year":"2022","unstructured":"Patone M, Mei XW, Handunnetthi L, et al.. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med. 2022, 28:410-22. 10.1038\/s41591-021-01630-0","journal-title":"Nat Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116803","article-title":"Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic","volume":"412","author":"Jacob S","year":"2020","unstructured":"Jacob S, Muppidi S, Guidon A, et al.. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. J Neurol Sci. 2020, 412:116803. 10.1016\/j.jns.2020.116803","journal-title":"J Neurol Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta P","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020, 395:1033-4. 10.1016\/S0140-6736(20)30628-0","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2021.09.065","article-title":"Thrombosis formation after COVID-19 vaccination immunological aspects: review article","volume":"29","author":"Waggiallah HA","year":"2022","unstructured":"Waggiallah HA. Thrombosis formation after COVID-19 vaccination immunological aspects: review article. Saudi J Biol Sci. 2022, 29:1073-8. 10.1016\/j.sjbs.2021.09.065","journal-title":"Saudi J Biol Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G104","article-title":"Myocardial infarction associated with intravenous immune globulin","volume":"39","author":"Stenton SB","year":"2005","unstructured":"Stenton SB, Dalen D, Wilbur K. Myocardial infarction associated with intravenous immune globulin. Ann Pharmacother. 2005, 39:2114-8. 10.1345\/aph.1G104","journal-title":"Ann Pharmacother"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcme.2014.08.003","article-title":"Cardiac manifestations of myasthenia gravis: a systematic review","volume":"5","author":"Shivamurthy P","year":"2014","unstructured":"Shivamurthy P, Parker MW. Cardiac manifestations of myasthenia gravis: a systematic review. IJC Metab Endocr. 2014, 5:3-6.","journal-title":"IJC Metab Endocr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/88969-an-interesting-case-of-fatal-myasthenic-crisis-probably-induced-by-the-covid-19-vaccine","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:49Z","timestamp":1707507349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/88969-an-interesting-case-of-fatal-myasthenic-crisis-probably-induced-by-the-covid-19-vaccine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,17]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.23251","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,17]]}}}